BioMarin Pharmaceutical Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. BioMarin Pharmaceutical Inc. - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
BioMarin Pharmaceutical (BioMarin) is engaged in development and commercialization of biopharmaceuticals. The company select product candidates for diseases and conditions that represent a significant unmet medical need, have well-understood biology and provide an opportunity to be first-to-market. The company primarily operates in the US. It is headquartered in Novato, California and employed 871 people as of January 21, 2011. The company recorded revenues of $376.3 million during the financial year (FY) ended December 2010, an increase of 15.9% over FY2009. The operating profit of the company was $0.5 million during FY2010, a decrease of 96.7% over FY2009. The net profit was $205.8 million in FY2010, as compared to a net loss of $0.5 million in FY2009.
Scope of the Report
Provides all the crucial information on BioMarin Pharmaceutical Inc. required for business and competitor intelligence needs
Contains a study of the major internal and external factors affecting BioMarin Pharmaceutical Inc. in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of BioMarin Pharmaceutical Inc.
Data is supplemented with details on BioMarin Pharmaceutical Inc. history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from BioMarin Pharmaceutical Inc.
Reasons to Purchase
Support sales activities by understanding your customers’ businesses better
Understand prospective partners and suppliers
Keep fully up to date on your competitors’ business structure, strategy and prospects
Obtain the most up to date company information available